The 21 references without contexts in paper O. Saprina A., О. Саприна А. (2015) “МЕТАСТАЗЫ ПЛОСКОКЛЕТОЧНОГО РАКА В ЛИМФАТИЧЕСКИЕ УЗЛЫ ШЕИ БЕЗ ВЫЯВЛЕННОГО ПЕРВИЧНОГО ОЧАГА // SQUAMOUS CELL CARCINOMA METASTASES TO THE CERVICAL LYMPH NODES WITHOUT A PRIMARY FOCUS BEING DETECTED” / spz:neicon:ogsh:y:2012:i:4:p:53-58

3
Guarischi A., Keane T.J., Elhakim T. Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases. Cancer 1987 Feb1;59(3):572−7.
(check this in PDF content)
4
Muir C. Cancer of unknown primary site. Cancer 1995 Jan 1;75(1 Suppl):353−6.
(check this in PDF content)
5
Seddon D.J., Williams E.M. Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry. Br J Cancer 1997; 76(5):667−74.
(check this in PDF content)
9
Cheng A.T.L., Dorman B. Fine needle aspiration cytology: the Auckland experience. Aust N Z J Surg 1992; 62(5):368−72.
(check this in PDF content)
10
Rapkiewicz A., Le B.T., Simsir A. et al. Spectrum of head and neck lesions diagnosed by fine-needle aspiration cytology in the pediatric population. Cancer 2007;
(check this in PDF content)
11
4):242−51. 11. Murthy P., Laing M.R., Palmer T.J. Fine needle aspiration cytology of head and neck lesions: an early experience. J R Coll Surg Edinb 1997;42(5):341−6.
(check this in PDF content)
16
Greven K.M., Keyes J.W. Jr, Williams D. III, et al. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer 1999;86(1):114−8.
(check this in PDF content)
17
Fogarty G.B., Peters L.J., Stewart J. et al. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck 2003;25(2):138−45.
(check this in PDF content)
23
McQuone S.J., Eisele D.W., Lee D.-J. et al. Occult tonsillar carcinoma in the unknown primary. Laryngoscope 1998; 108(11):1605−10.
(check this in PDF content)
24
Randall D.A., Johnstone P.A.S., Foss R.D. et al. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg 2000; 122(1):52−5.
(check this in PDF content)
28
Bataini J.P., Rodriguez J., Jaulerry C. et al. Treatment of metastatic neck nodes secondary to an occult epidermoid carcinoma of the head and neck. Laryngoscope 1987;97:1080−4.
(check this in PDF content)
29
Carlson L.S., Fletcher G.H., Oswald M.J. Guidelines for radiotherapeutic techniques for cervical metastases from an unknown primary. Int J Radiat Oncol Biol Phys 1986;12:2101−10.
(check this in PDF content)
30
Lefebvre J.L., Coche-Dequeant B., Van J.T. et al. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg 1990;160:443−6.
(check this in PDF content)
31
McCunniff A.J., Raben M. Metastatic carcinoma of the neck from an unknown primary. Int J Radiat Oncol Biol Phys 1986; 12:1849−52.
(check this in PDF content)
33
Weir L., Keane T., Cummings B. et al. Radiation treatment of cervical lymph node metastases from an unknown primary: An analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 1995;35:206−11.
(check this in PDF content)
35
LeChevalier T., Cvitkovic E., Caille P. et al. Early metastatic cancer of unknown primary origin at presentation. Arch Intern Med 1988;148:2035−9.
(check this in PDF content)
36
Lembersky B.C., Thomas L.C. Metastases of unknown primary site. Med Clin North Am 1996;80:153−71.
(check this in PDF content)
37
Muir С. Cancer of unknown primary site. Cancer 1995;1:353−6.
(check this in PDF content)
38
Pasterz R., Savoraj N., Burgess M. Prognostic factors in metastatic carcinoma of unknown primary. J Clin Oncol 1986; 4:1652−7.
(check this in PDF content)
39
Pentheroudakis G., Briasoulis E., Pavlidis N. Cancer of unknown primary site: missing primary or missing biology? Oncologist 2007;12:418−25.
(check this in PDF content)
40
Wouw A.J., Janssen-Heijnen M.L., Coebergh J.W. et al. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984−1992. Eur J Cancer 2002;38:409−13.
(check this in PDF content)